How Much Radiation Is in a PET-CT — Compared With Radiotherapy?

That gap sounds alarming until you see what each number is for. A PET-CT is designed to give the smallest dose that still produces an image good enough to answer a clinical question, and that dose is deliberately diluted across the whole body. Radiotherapy is designed to do the opposite: concentrate a prescribed dose inside a planned volume, fraction by fraction, while the organs around it are held under agreed limits.

So the two are not competing on the same scale, and neither number tells you anything useful about the other. A patient who has had four PET-CT scans has not had “a bit of radiotherapy”. A patient finishing radiotherapy has not received “thousands of scans’ worth of risk” either, because that dose went into a defined target, not into every organ.

Ranges reflect widely published diagnostic-imaging and radiotherapy dose data referenced by WHO and international radiation-protection (ICRP) guidance, alongside ASTRO and NCCN treatment-dose conventions. Figures are approximate and indicative as of August 2026 — ask your own radiology or radiation oncology team for the exact numbers used in your case.

Think of it as the difference between a rainfall figure and a fire-hose figure. Effective dose in mSv is a risk-estimation tool for everyday, low-level exposure — background radiation, an X-ray, a CT, a PET-CT. It exists so that a radiologist can weigh a small probability against a diagnostic benefit.

Absorbed dose in Gy is a delivery specification. When a radiation oncologist writes 60 Gy in 30 fractions, that is an instruction: this volume, this much energy, this many sittings. It is checked by a medical physicist against dose limits for every organ nearby before a single fraction is delivered. Nobody uses effective dose for that, because a whole-body average is meaningless when the entire point is that the dose is not whole-body.

This is also why an internet search that puts “20 mSv” against “60 Gy” and stops there is misleading. The scale is real, but so is the targeting, the fractionation and the planning that surround the larger number.

There is no published number of PET-CT scans after which a person is declared unsafe, and any site that offers you one has invented it. Instead, international radiation-protection guidance rests on two principles that radiologists and nuclear-medicine physicians apply to every request: justification, meaning the scan is expected to change your diagnosis, staging or treatment, and optimisation (often called ALARA, As Low As Reasonably Achievable), meaning the dose used is the lowest that still answers the question.

The practical consequence is simple. Your prior imaging history should be reviewed before another scan is ordered, and you are entitled to ask whether that happened. Keeping your own dated list of every CT, PET-CT and X-ray — on your phone is fine — makes that review far easier for whichever doctor sees you next.

If you are being scanned repeatedly during treatment or surveillance, our guide to repeated X-rays and scans during cancer follow-up goes through the cumulative picture in more detail.

NCCN survivorship and site-specific guidance leans on clinical review, physical examination, blood tests and targeted imaging for most cancers, rather than scheduled whole-body PET-CT. That is not a cost-saving position. A scan ordered without a specific question adds dose, adds waiting, and frequently picks up findings of no consequence that then need further tests to settle.

Two further things are worth knowing if a PET-CT is being planned soon after radiotherapy. Treated tissue can stay inflamed and take up the tracer for weeks to months, which can look active on the scan without meaning the disease is active. For that reason teams usually leave a deliberate gap after finishing radiotherapy before a PET-CT is read as a response assessment. If your scan is being scheduled sooner than you expected, ask what the timing is based on.

The reasonable thing to expect is a written follow-up schedule that says what happens at each visit and what would trigger a scan. If you do not have one, ask for it — it removes most of the guesswork, and most of the anxiety.

Your PET-CT is carried out at an NABH-accredited partner imaging centre and your radiotherapy at an NABH-accredited partner radiotherapy centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout.

• If your real concern is the running total rather than any one scan, Are Repeated X-Rays and Scans During Cancer Follow-Up Harmful? works through cumulative exposure during surveillance.
• If you carry a BRCA result and want to know whether radiation is riskier for you specifically, BRCA Carriers and Radiation Sensitivity: What the Evidence Says separates what is established from what is still uncertain.
• If a sibling or parent has had cancer and you are wondering when to start screening, Should You Screen Earlier If a Sibling or Parent Had Cancer? explains how that decision is actually made.
• If there is a diagnosed syndrome in the family, Genetic Syndromes Where Radiation Needs Extra Caution covers the conditions where imaging and treatment planning genuinely change.
• For the wider picture of how radiotherapy is planned, delivered and coordinated with NABH-accredited partner centres, see our Radiation Therapy at CION Cancer Clinics hub.

Still unsure what your own scan history adds up to, or whether the next one is justified? Book a free consultation and a radiation oncologist will go through it with you, or call 1800 202 8726.